(Date:8/28/2008)...d clinical efforts of the Maryland Medicaid contra...O, a national medical,management firm, appointed L...l Director. Dr. Lawyer will oversee all clinical a...ePRO,s Hunt Valley, Maryland Harrisburg,office., ...r in Maryland," said,Alice Stollenwerk Petrulis, M...
(Date:8/28/2008)...be based in the Northeast region with more hires,p... HARRISBURG, Pa., Aug. 28 /PRNewswire-USNewswire/ ...ired a Patient Safety Liaison for the,Northeast re...the,Pennsylvania Patient Safety Reporting System (...itizens., "Last year in focus groups with Pennsyl...
(Date:8/28/2008)...roke risk by 67%, but patients and doctors say dru...8 (HealthDay News) -- Only 40 percent of patients ...stroke, who did suffer a stroke were taking the an... Among those taking warfarin, 75 percent weren,t g... additional 25 percent were taking medications tha...
(Date:8/28/2008)... Leading dermatology company serves growing pr... Palo Alto, CA (PRWEB) August 28...e capital firm, today announced that together with..., is leading a Series A round of financing for Pro...intly invested $15.5 million in the round. Profex,...
Breaking Medicine News(10 mins):Health News:Lenaye Lawyer, MD, FACOG, Named KePRO Medical Director 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3Health News:Most Patients With Irregular Heartbeat Take Inadequate Blood Thinner Dose 2Health News:Most Patients With Irregular Heartbeat Take Inadequate Blood Thinner Dose 3Health News:Trident Capital and Mustang Ventures Lead Series A Investment in Profex, Inc. 2Health News:Trident Capital and Mustang Ventures Lead Series A Investment in Profex, Inc. 3(Date:8/25/2008)... to New Prevention and Treatment Strategies--, PH...entists have,discovered gene mutations that are th...hood cancer neuroblastoma. In addition, the resear...cant role in high-risk forms of,non-inherited neur..."This discovery enables us to offer the first gene...
(Date:8/25/2008)...LL, NHL and CLL Retreatment and Japanese Developme... COPENHAGEN, Denmark, August 25 /PRNewswire-First...studies of ofatumumab in chronic lymphocytic,leuke... GEN) announced today plans to begin four studies ...) and follicular,non-Hodgkin,s lymphoma (NHL) this...
(Date:8/21/2008)...ation Awareness Campaign Addresses Knowledge Gap, ...Not the Only Important Choice to .... 21 /- A new survey of parents of,ei...ext to last among,things they believe they can do ...ugh public health guidelines state that getting an...
(Date:8/21/2008)...now(R) assay suggests clinical potential in indepe...nsplant patients, COLUMBIA, Md., Aug. 21 /PRNewsw...hed in the peer-reviewed journal Liver Transplanta...the clinical potential of monitoring,cell- mediate...post-transplantation., Working in a cooperative g...
Breaking Medicine Technology:Gene That Causes Childhood Cancer Neuroblastoma Is Found 2Gene That Causes Childhood Cancer Neuroblastoma Is Found 3Gene That Causes Childhood Cancer Neuroblastoma Is Found 4Genmab Announces Upcoming Ofatumumab Studies 2Genmab Announces Upcoming Ofatumumab Studies 3Genmab Announces Upcoming Ofatumumab Studies 4Survey Shows Parents' Best Intentions Out of Step with Expert Recommendations in Protecting Kids from Flu 2Survey Shows Parents' Best Intentions Out of Step with Expert Recommendations in Protecting Kids from Flu 3Survey Shows Parents' Best Intentions Out of Step with Expert Recommendations in Protecting Kids from Flu 4Survey Shows Parents' Best Intentions Out of Step with Expert Recommendations in Protecting Kids from Flu 5New Data Support Earlier Suggested Guidance for Levels of Cell-Mediated Immunity in Pediatric Liver Transplant Patients 2New Data Support Earlier Suggested Guidance for Levels of Cell-Mediated Immunity in Pediatric Liver Transplant Patients 3Medivations Dimebon 28TM 29 Significantly Improved Thinking and Memory in Alzheimers Disease Patients Over One Year 1846 1Medivations Dimebon 28TM 29 Significantly Improved Thinking and Memory in Alzheimers Disease Patients Over One Year 1846 2Medivations Dimebon 28TM 29 Significantly Improved Thinking and Memory in Alzheimers Disease Patients Over One Year 1846 3Medivations Dimebon 28TM 29 Significantly Improved Thinking and Memory in Alzheimers Disease Patients Over One Year 1846 4Common Medications May Harm Memory in Older People 17155 1Common Medications May Harm Memory in Older People 17155 2Common Medications May Harm Memory in Older People 17155 3Penn researchers find potential in yeast for selecting Lou Gehrigs disease drugs 17151 1Penn researchers find potential in yeast for selecting Lou Gehrigs disease drugs 17151 2LodgeNet Appoints John E Haire Former Time Warner Executive to Board of Directors 17147 1LodgeNet Appoints John E Haire Former Time Warner Executive to Board of Directors 17147 2...ch 28, 2007,/PRNewswire-FirstCall/ -- Biosite Inco...sample collection study aimed at,identifying a bio...essment for risk of sepsis progression. Sepsis is ...options. Clinical investigator,Emanuel P. Rivers,... at the department of emergency medicine at Henry ...
...27, 2007 - Interleukin,Genetics, Inc. (AMEX:ILI) a...an Diego today reported at the American College of...en coronary artery,disease (CAD) and both oxidized...e dependent on pro-inflammatory variants of the,in...d "The Influence of Oxidized,Phospholipids and Lp(...
Other Medicine Technology:Biosite Reports on Presentation of Preliminary Data From Sepsis,Program 2Biosite Reports on Presentation of Preliminary Data From Sepsis,Program 3Biosite Reports on Presentation of Preliminary Data From Sepsis,Program 4Biosite Reports on Presentation of Preliminary Data From Sepsis,Program 5ACC Presentation Indicates Interleukin-1 Gene Variants Determine,Increased Risk for Coronary Artery Disease from Oxidized,Phospholipids 2ACC Presentation Indicates Interleukin-1 Gene Variants Determine,Increased Risk for Coronary Artery Disease from Oxidized,Phospholipids 3Alpina Uni Knee Prosthesis is designed to meet anatomical requirements and particularly the differences between medial and lateral femoral condyles.
The Genesis II total knee system defines the state of knee implants.
The Duracon tibial inserts have radiused A/P and M/L dishes produced by advanced 4-axis machining, maximizing conformity of the tibial insert to the radiused condyles of the femoral component. The re
...al total knee prosthesis stems from many years of ...t design and manufacturing technologies have been ...ction as well as a favorable pressure distribution... wear to a minimum. The inherent design of the com...
Medicine Products: